McCauley et al. [99] were able to rescue the swelling function of CF-patient-derived organoids by gene editing and Hirai et al. [101] showed that human lung organoids derived from pluripotent stem cells modelling CF can be used for drug testing of CFTR modulators by performing a forskolin-stimulation swelling test. Here, CFTR is linked to cystic fibrosis.